_1782605483653-86ykd14Q.png)
There is a particular silence that settles over a boardroom when the renewal letter comes out. The CFO reads the number twice. Someone asks whether it's a typo. It is not a typo.
For most Canadian employers, the 2026 renewal season is shaping up to be one of the steepest in a decade. The headline figure circulating among benefits consultants is a trend of roughly 7 to 12 percent on a fully insured block — and that's before anyone touches the design of the plan. The interesting question isn't whether your premiums are going up. They are. The interesting question is why, because the "why" is where the savings hide.
Three forces, pulling in the same direction
Renewal math feels mysterious from the outside, but it's mostly the sum of three pressures that all happen to be climbing at once in 2026.
The first is drugs — specifically the GLP-1 class (Ozempic, Wegovy, Mounjaro) that has rewired drug spending across the country. Benefits analysts now attribute on the order of 1.5 to 3 percentage points of total trend to specialty and weight-management drugs alone. A single plan member on a GLP-1 can cost a plan north of $4,000 a year, and the number of members asking is not going down.
The second is paramedical — psychology, physiotherapy, massage, the whole menu of practitioner services. Utilization climbed sharply post-pandemic and never fully retreated. When you raised your mental-health maximum (and most employers have), you didn't just add a line item; you added a behaviour. People use what they're told they have.
The third is dental, the quiet one. Provincial fee guides rise every year, and 2026's increases land at a moment when deferred pandemic-era care is still working its way through the system.
Stack those together and you get the trend. But here's the part most renewal letters won't tell you: a meaningful slice of your increase isn't about claims at all. It's about how your insurer has pooled, credibility-weighted, and target-loss-ratioed your group. Translation: some of the number is medical inflation, and some of it is negotiable.
The renewal letter is an opening offer, not a verdict
Here's a thing worth sitting with. An insurer's first renewal is, structurally, an anchor. It is calculated to be defensible, not generous. The size of the group determines how much of your own claims experience actually drives the number — a concept called credibility.
- A group of 10 employees is almost entirely pooled. Your renewal reflects the insurer's book, not your people. One bad claim doesn't move it much; neither does one great year.
- A group of 75 is partially credible. Your experience matters, but it's blended with the pool.
- A group of 300+ is largely self-credible. Your renewal is mostly a mirror of your own claims — which means it's mostly within your control.
Why does this matter? Because the cost-containment lever that works brilliantly for a 300-life group can be irrelevant for a 15-life group, and vice versa. Anyone who quotes you a single "here's how to cut benefits costs" playbook without first asking your headcount is selling, not advising.
Seven levers, ranked by how much they actually move the needle
Over a few hundred renewals, a pattern emerges. These are the levers that consistently produce savings, roughly in order of impact for a typical 50-to-500-life Canadian employer:
- Marketing the plan to competing insurers. The single most reliable lever. A credible alternative quote does more to discipline a renewal than any conversation. Insurers price differently for the same risk, and they price more sharply when they know they're being watched.
- Pooling and stop-loss adjustments. For larger groups, where you set the pooling threshold quietly determines how much volatility hits your renewal. Most plans are pooled at a level chosen years ago and never revisited.
- Drug plan management — generic substitution, prior authorization, managed formularies, and a deliberate GLP-1 strategy (more on that in another post). This is where the fastest-growing cost lives, so it's where discipline compounds.
- Dental fee guide and recall frequency. Capping reimbursement at the current-year guide and moving recall from six to nine months are nearly invisible to employees and quietly material to cost.
- Plan design tuning — coinsurance, deductibles, and maximums calibrated to actual usage rather than to a competitor's brochure.
- A Health Spending Account layer. Replacing rich, open-ended coverage with a defined HSA dollar amount converts an unpredictable liability into a budget line. More on the HSA-versus-traditional math below.
- Plan-member communication. The cheapest lever and the most ignored. People who understand their plan use it better; over-utilization is often just confusion wearing a costume.
HSA vs. traditional: the comparison nobody runs honestly
A Health Spending Account (HSA) lets you give each employee a fixed pool of tax-effective dollars to spend across eligible health and dental expenses. A traditional plan promises specific coverage at specific reimbursement levels, open-ended within its maximums.
The honest comparison looks like this:
| Traditional plan | Health Spending Account | |
|---|---|---|
| Cost predictability | Variable — you ride the trend | Fixed — you set the dollar amount |
| Employee perception | "Comprehensive," familiar | "Flexible," but feels like a budget |
| Inflation exposure | High | You control it |
| Best for | Risk-averse, claims-heavy groups | Cost-certain budgeting, diverse needs |
Neither is universally better. A young, healthy, geographically scattered workforce often gets more satisfaction per dollar from an HSA. A claims-heavy group with chronic conditions may find a traditional plan genuinely cheaper in total risk-adjusted cost. The mistake is treating the choice as ideological rather than empirical — running the actual numbers on your claims rather than adopting whatever a peer company did.
What a disciplined renewal actually looks like
The employers who beat their renewal don't have a secret. They have a sequence. They start the process 120 days out, not 30. They get a clean claims experience report and read it. They test the market quietly before the incumbent's renewal lands, so the first number arrives already knowing it has competition. And they separate the part of the increase that's genuine medical inflation — which you absorb or design around — from the part that's negotiating posture, which you push back on.
Done well, a 9 percent renewal becomes a 2 to 4 percent renewal. That's not a rounding error. On a $500,000 annual spend, it's the difference between $45,000 and $15,000 of new cost — every year, compounding.
The renewal letter is going to hurt. How much it hurts, and for how long, is more in your hands than the letter would have you believe.
